Danielle Roman

584 total citations
27 papers, 358 citations indexed

About

Danielle Roman is a scholar working on Molecular Biology, Immunology and Ophthalmology. According to data from OpenAlex, Danielle Roman has authored 27 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Ophthalmology. Recurrent topics in Danielle Roman's work include Glaucoma and retinal disorders (6 papers), Ocular Surface and Contact Lens (4 papers) and Carcinogens and Genotoxicity Assessment (3 papers). Danielle Roman is often cited by papers focused on Glaucoma and retinal disorders (6 papers), Ocular Surface and Contact Lens (4 papers) and Carcinogens and Genotoxicity Assessment (3 papers). Danielle Roman collaborates with scholars based in Switzerland, United States and Austria. Danielle Roman's co-authors include R. Markstein, María Bobadilla, Willi Suter, Vicente Nogués, André Cordier, Elke Persohn, Ursula Junker, Daniel Roth, Wolfgang Seewald and Estelle Marrer and has published in prestigious journals such as Biochemical Pharmacology, Toxicology and Applied Pharmacology and Experimental Eye Research.

In The Last Decade

Danielle Roman

27 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danielle Roman Switzerland 11 101 60 59 52 49 27 358
Sven Kronenberg Switzerland 12 162 1.6× 43 0.7× 27 0.5× 12 0.2× 60 1.2× 23 426
Robert H. Denlinger United States 12 225 2.2× 28 0.5× 65 1.1× 13 0.3× 128 2.6× 16 516
Johan Willemse Belgium 11 91 0.9× 152 2.5× 59 1.0× 70 1.3× 62 1.3× 18 333
Dawn A. Bradbury United Kingdom 8 149 1.5× 22 0.4× 60 1.0× 12 0.2× 81 1.7× 9 396
Shuichi Miyaura Japan 10 198 2.0× 30 0.5× 47 0.8× 32 0.6× 26 0.5× 23 465
Rubén Fernández‐Rodríguez Spain 11 181 1.8× 26 0.4× 92 1.6× 12 0.2× 149 3.0× 12 431
I. Jaffe United States 11 147 1.5× 28 0.5× 77 1.3× 10 0.2× 32 0.7× 19 475
M Kuriyama Japan 16 260 2.6× 13 0.2× 47 0.8× 30 0.6× 65 1.3× 33 571
Shannon M. White United States 11 269 2.7× 21 0.3× 64 1.1× 10 0.2× 124 2.5× 23 637
Vicki L. Nebes United States 12 188 1.9× 31 0.5× 62 1.1× 10 0.2× 33 0.7× 23 472

Countries citing papers authored by Danielle Roman

Since Specialization
Citations

This map shows the geographic impact of Danielle Roman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle Roman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle Roman more than expected).

Fields of papers citing papers by Danielle Roman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danielle Roman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle Roman. The network helps show where Danielle Roman may publish in the future.

Co-authorship network of co-authors of Danielle Roman

This figure shows the co-authorship network connecting the top 25 collaborators of Danielle Roman. A scholar is included among the top collaborators of Danielle Roman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danielle Roman. Danielle Roman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roman, Danielle, et al.. (2018). ASHP-HOPA guidelines on the roles and responsibilities of the pharmacy technician in ambulatory oncology pharmacy. American Journal of Health-System Pharmacy. 75(17). 1304–1311. 1 indexed citations
2.
Roman, Danielle, James N. Ver Hoeve, Heiko S. Schadt, et al.. (2016). Ocular toxicity of AUY922 in pigmented and albino rats. Toxicology and Applied Pharmacology. 309. 55–62. 5 indexed citations
3.
Roman, Danielle, et al.. (2015). Vemurafenib: First-in-Class BRAF-Mutated Inhibitor for the Treatment of Unresectable or Metastatic Melanoma. Journal of the Advanced Practitioner in Oncology. 6(4). 361–5. 19 indexed citations
4.
Roman, Danielle, et al.. (2013). Regorafenib: Adding to the Armamentarium for Refractory Colorectal Cancer and GIST. Journal of the Advanced Practitioner in Oncology. 4(2). 118–22. 3 indexed citations
5.
Wolf, Armin, Philippe Couttet, Min Dong, et al.. (2010). Imatinib does not induce cardiotoxicity at clinically relevant concentrations in preclinical studies. Leukemia Research. 34(9). 1180–1188. 58 indexed citations
6.
Wolf, Armin, Philippe Couttet, Min Dong, et al.. (2010). Preclinical evaluation of potential nilotinib cardiotoxicity. Leukemia Research. 35(5). 631–637. 16 indexed citations
7.
Markstein, R., et al.. (2009). Antiglaucoma drug GLC756 and its effect on cellular cAMP and tumor necrosis factor α release in vitro of activated human monocytic leukemia cells. Japanese Journal of Ophthalmology. 53(2). 159–163. 3 indexed citations
8.
Markstein, R., et al.. (2007). Effects of latanoprost, timolol and GLC756, a novel dopamine D2 agonist and D1 antagonist on LTC4 release after rat mast cell activation. Clinical and Experimental Ophthalmology. 35(7). 645–650. 4 indexed citations
9.
10.
Roman, Danielle, et al.. (2006). The minipig in dermatotoxicology: Methods and challenges. Experimental and Toxicologic Pathology. 57(5-6). 341–345. 56 indexed citations
11.
Roth, Daniel, Danielle Roman, Peter Ulrich, et al.. (2006). Design and evaluation of immunotoxicity studies. Experimental and Toxicologic Pathology. 57(5-6). 367–371. 15 indexed citations
12.
Trendelenburg, Anne U., et al.. (2006). GLC756 decreases TNF-α via an alpha2 and beta2 adrenoceptor related mechanism. Experimental Eye Research. 83(5). 1246–1251. 8 indexed citations
13.
Markstein, R., et al.. (2006). Effects of Antiglaucoma Drugs GLC756, a Novel Dopamine D2 Agonist and D1 Antagonist, and Timolol on Endotoxin-Induced TNF-Alpha Release in Serum of Rats. European Journal of Ophthalmology. 16(3). 401–406. 6 indexed citations
14.
15.
Roman, Danielle. (2004). Determination of the effect of calcineurin inhibitors on the rat's immune system after KLH immunisation. Toxicology Letters. 149(1-3). 133–140. 13 indexed citations
16.
Medina, J., Andreas Mahl, Danielle Roman, et al.. (2003). LAV694, a new antiproliferative agent showing improved skin tolerability vs. clinical standards for the treatment of actinic keratosis. Biochemical Pharmacology. 66(10). 1885–1895. 5 indexed citations
17.
Greiner, Bernd, et al.. (2003). 147 Effects of latanoprost and GLC756, a novel dopamine D2 agonist and D1 antagonist, on cultured normal human dermal fibroblasts. Toxicology Letters. 144. s42–s43. 1 indexed citations
18.
Roman, Danielle & Paul‐Georg Germann. (2002). Laser technologies in toxicopathology. Experimental and Toxicologic Pathology. 54(2). 169–170. 1 indexed citations
19.
Roman, Danielle, et al.. (1998). Evaluation of a new procedure for the flow cytometric analysis of in vitro, chemically induced micronuclei in V79 cells. Environmental and Molecular Mutagenesis. 32(4). 387–396. 26 indexed citations
20.
Roman, Danielle & María Bobadilla. (1998). Flow cytometry as a valuable tool in toxicology. Toxicology Letters. 95. 198–198. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sven Kronenberg Breakdown of academic impact, for papers by Robert H. Denlinger Breakdown of academic impact, for papers by Johan Willemse Breakdown of academic impact, for papers by Dawn A. Bradbury Breakdown of academic impact, for papers by Shuichi Miyaura Breakdown of academic impact, for papers by Rubén Fernández‐Rodríguez Breakdown of academic impact, for papers by I. Jaffe Breakdown of academic impact, for papers by M Kuriyama Breakdown of academic impact, for papers by Shannon M. White Breakdown of academic impact, for papers by Vicki L. Nebes
Rankless by CCL
2026